Exact Mass: 505.2359
Exact Mass Matches: 505.2359
Found 500 metabolites which its exact mass value is equals to given mass value 505.2359
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Amprenavir
Amprenavir is only found in individuals that have used or taken this drug. It is a protease inhibitor used to treat HIV infection.Amprenavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
Benidipine
Triletide
Lys Glu Thr Glu
Amprenavir
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
Benidipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Ala Glu Met Arg
Ala Glu Arg Met
Ala Met Glu Arg
Ala Met Arg Glu
Ala Met Val Trp
Ala Met Trp Val
Ala Arg Glu Met
Ala Arg Met Glu
Ala Val Met Trp
Ala Val Trp Met
Ala Trp Met Val
Ala Trp Val Met
Cys Asp Ile Arg
Cys Asp Leu Arg
Cys Asp Arg Ile
Cys Asp Arg Leu
Cys Glu Arg Val
Cys Glu Val Arg
Cys Ile Asp Arg
Cys Ile Arg Asp
Cys Lys Gln Gln
Cys Leu Asp Arg
Cys Leu Arg Asp
Cys Gln Lys Gln
Cys Gln Gln Lys
Cys Arg Asp Ile
Cys Arg Asp Leu
Cys Arg Glu Val
Cys Arg Ile Asp
Cys Arg Leu Asp
Cys Arg Val Glu
Cys Val Glu Arg
Cys Val Arg Glu
Cys Val Val Trp
Cys Val Trp Val
Cys Trp Val Val
Asp Cys Ile Arg
Asp Cys Leu Arg
Asp Cys Arg Ile
Asp Cys Arg Leu
Asp Ile Cys Arg
Asp Ile Met Gln
Asp Ile Gln Met
Asp Ile Arg Cys
Asp Leu Cys Arg
Asp Leu Met Gln
Asp Leu Gln Met
Asp Leu Arg Cys
Asp Met Ile Gln
Asp Met Leu Gln
Asp Met Gln Ile
Asp Met Gln Leu
Asp Gln Ile Met
Asp Gln Leu Met
Asp Gln Met Ile
Asp Gln Met Leu
Asp Arg Cys Ile
Asp Arg Cys Leu
Asp Arg Ile Cys
Asp Arg Leu Cys
Glu Ala Met Arg
Glu Ala Arg Met
Glu Cys Arg Val
Glu Cys Val Arg
Glu Glu Lys Thr
Glu Glu Thr Lys
Glu Ile Met Asn
Glu Ile Asn Met
Glu Lys Glu Thr
Glu Lys Thr Glu
Glu Leu Met Asn
Glu Leu Asn Met
Glu Met Ala Arg
Glu Met Ile Asn
Glu Met Leu Asn
Glu Met Asn Ile
Glu Met Asn Leu
Glu Met Gln Val
Glu Met Arg Ala
Glu Met Val Gln
Glu Asn Ile Met
Glu Asn Leu Met
Glu Asn Met Ile
Glu Asn Met Leu
Glu Gln Met Val
Glu Gln Val Met
Glu Arg Ala Met
Glu Arg Cys Val
Glu Arg Met Ala
Glu Arg Thr Thr
Glu Arg Val Cys
Glu Thr Glu Lys
Glu Thr Lys Glu
Glu Thr Arg Thr
Glu Thr Thr Arg
Glu Val Cys Arg
Glu Val Met Gln
Glu Val Gln Met
Glu Val Arg Cys
Phe Gly Pro Trp
Phe Gly Trp Pro
Phe Pro Gly Trp
Phe Pro Trp Gly
Phe Trp Gly Pro
Phe Trp Pro Gly
Gly Phe Pro Trp
Gly Phe Trp Pro
Gly His His Arg
Gly His Arg His
Gly Ile Met Trp
Gly Ile Trp Met
Gly Leu Met Trp
Gly Leu Trp Met
Gly Met Ile Trp
Gly Met Leu Trp
Gly Met Trp Ile
Gly Met Trp Leu
Gly Pro Phe Trp
Gly Pro Trp Phe
Gly Arg His His
Gly Trp Phe Pro
Gly Trp Ile Met
Gly Trp Leu Met
Gly Trp Met Ile
Gly Trp Met Leu
Gly Trp Pro Phe
His Gly His Arg
His Gly Arg His
His His Gly Arg
His His Asn Val
His His Arg Gly
His His Val Asn
His Asn His Val
His Asn Val His
His Arg Gly His
His Arg His Gly
His Val His Asn
His Val Asn His
Ile Cys Asp Arg
Ile Cys Arg Asp
Ile Asp Cys Arg
Ile Asp Met Gln
Ile Asp Gln Met
Ile Asp Arg Cys
Ile Glu Met Asn
Ile Glu Asn Met
Ile Gly Met Trp
Ile Gly Trp Met
Ile Met Asp Gln
Ile Met Glu Asn
Ile Met Gly Trp
Ile Met Asn Glu
Ile Met Gln Asp
Ile Met Trp Gly
Ile Asn Glu Met
Ile Asn Met Glu
Ile Gln Asp Met
Ile Gln Met Asp
Ile Arg Cys Asp
Ile Arg Asp Cys
Ile Trp Gly Met
Ile Trp Met Gly
Lys Cys Gln Gln
Lys Glu Glu Thr
Lys Met Met Pro
Lys Met Asn Asn
Lys Met Pro Met
Lys Asn Met Asn
Lys Asn Asn Met
Lys Pro Met Met
Lys Gln Cys Gln
Lys Gln Gln Cys
Lys Thr Glu Glu
Leu Cys Asp Arg
Leu Cys Arg Asp
Leu Asp Cys Arg
Leu Asp Met Gln
Leu Asp Gln Met
Leu Asp Arg Cys
Leu Glu Met Asn
Leu Glu Asn Met
Leu Gly Met Trp
Leu Gly Trp Met
Leu Met Asp Gln
Leu Met Glu Asn
Leu Met Gly Trp
Leu Met Asn Glu
Leu Met Gln Asp
Leu Met Trp Gly
Leu Asn Glu Met
Leu Asn Met Glu
Leu Gln Asp Met
Leu Gln Met Asp
Leu Arg Cys Asp
Leu Arg Asp Cys
Leu Trp Gly Met
Leu Trp Met Gly
Met Ala Glu Arg
Met Ala Arg Glu
Met Ala Val Trp
Met Ala Trp Val
Met Asp Ile Gln
Met Asp Leu Gln
Met Asp Gln Ile
Met Asp Gln Leu
Met Glu Ala Arg
Met Glu Ile Asn
Met Glu Leu Asn
Met Glu Asn Ile
Met Glu Asn Leu
Met Glu Gln Val
Met Glu Arg Ala
Met Glu Val Gln
Met Gly Ile Trp
Met Gly Leu Trp
Met Gly Trp Ile
Met Gly Trp Leu
Met Ile Asp Gln
Met Ile Glu Asn
Met Ile Gly Trp
Met Ile Asn Glu
Met Ile Gln Asp
Met Ile Trp Gly
Met Lys Met Pro
Met Lys Asn Asn
Met Lys Pro Met
Met Leu Asp Gln
Met Leu Glu Asn
Met Leu Gly Trp
Met Leu Asn Glu
Met Leu Gln Asp
Met Leu Trp Gly
Met Met Lys Pro
Met Met Pro Lys
Met Asn Glu Ile
Met Asn Glu Leu
Met Asn Ile Glu
Met Asn Lys Asn
Met Asn Leu Glu
Met Asn Asn Lys
Met Pro Lys Met
Met Pro Met Lys
Met Gln Asp Ile
Met Gln Asp Leu
Met Gln Glu Val
Met Gln Ile Asp
Met Gln Leu Asp
Met Gln Val Glu
Met Arg Ala Glu
Met Arg Glu Ala
Met Val Ala Trp
Met Val Glu Gln
Met Val Gln Glu
Met Val Trp Ala
Met Trp Ala Val
Met Trp Gly Ile
Met Trp Gly Leu
Met Trp Ile Gly
Met Trp Leu Gly
Met Trp Val Ala
Asn Glu Ile Met
Asn Glu Leu Met
Asn Glu Met Ile
Asn Glu Met Leu
Asn His His Val
Asn His Val His
Asn Ile Glu Met
Asn Ile Met Glu
Asn Lys Met Asn
Asn Lys Asn Met
Asn Leu Glu Met
Asn Leu Met Glu
Asn Met Glu Ile
Asn Met Glu Leu
Asn Met Ile Glu
Asn Met Lys Asn
Asn Met Leu Glu
Asn Met Asn Lys
Asn Asn Lys Met
Asn Asn Met Lys
Asn Val His His
Pro Phe Gly Trp
Pro Phe Trp Gly
Pro Gly Phe Trp
Pro Gly Trp Phe
Pro Lys Met Met
Pro Met Lys Met
Pro Met Met Lys
Pro Trp Phe Gly
Pro Trp Gly Phe
Gln Cys Lys Gln
Gln Cys Gln Lys
Gln Asp Ile Met
Gln Asp Leu Met
Gln Asp Met Ile
Gln Asp Met Leu
Gln Glu Met Val
Gln Glu Val Met
Gln Ile Asp Met
Gln Ile Met Asp
Gln Lys Cys Gln
Gln Lys Gln Cys
Gln Leu Asp Met
Gln Leu Met Asp
Gln Met Asp Ile
Gln Met Asp Leu
Gln Met Glu Val
Gln Met Ile Asp
Gln Met Leu Asp
Gln Met Val Glu
Gln Gln Cys Lys
Gln Gln Lys Cys
Gln Val Glu Met
Gln Val Met Glu
Arg Ala Glu Met
Arg Ala Met Glu
Arg Cys Asp Ile
Arg Cys Asp Leu
Arg Cys Glu Val
Arg Cys Ile Asp
Arg Cys Leu Asp
Arg Cys Val Glu
Arg Asp Cys Ile
Arg Asp Cys Leu
Arg Asp Ile Cys
Arg Asp Leu Cys
Arg Glu Ala Met
Arg Glu Cys Val
Arg Glu Met Ala
Arg Glu Thr Thr
Arg Glu Val Cys
Arg Gly His His
Arg His Gly His
Arg His His Gly
Arg Ile Cys Asp
Arg Ile Asp Cys
Arg Leu Cys Asp
Arg Leu Asp Cys
Arg Met Ala Glu
Arg Met Glu Ala
Arg Thr Glu Thr
Arg Thr Thr Glu
Arg Val Cys Glu
Arg Val Glu Cys
Thr Glu Glu Lys
Thr Glu Lys Glu
Thr Glu Arg Thr
Thr Glu Thr Arg
Thr Lys Glu Glu
Thr Arg Glu Thr
Thr Arg Thr Glu
Thr Thr Glu Arg
Thr Thr Arg Glu
Val Ala Met Trp
Val Ala Trp Met
Val Cys Glu Arg
Val Cys Arg Glu
Val Cys Val Trp
Val Cys Trp Val
Val Glu Cys Arg
Val Glu Met Gln
Val Glu Gln Met
Val Glu Arg Cys
Val His His Asn
Val His Asn His
Val Met Ala Trp
Val Met Glu Gln
Val Met Gln Glu
Val Met Trp Ala
Val Asn His His
Val Gln Glu Met
Val Gln Met Glu
Val Arg Cys Glu
Val Arg Glu Cys
Val Val Cys Trp
Val Val Trp Cys
Val Trp Ala Met
Val Trp Cys Val
Val Trp Met Ala
Val Trp Val Cys
Trp Ala Met Val
Trp Ala Val Met
Trp Cys Val Val
Trp Phe Gly Pro
Trp Phe Pro Gly
Trp Gly Phe Pro
Trp Gly Ile Met
Trp Gly Leu Met
Trp Gly Met Ile
Trp Gly Met Leu
Trp Gly Pro Phe
Trp Ile Gly Met
Trp Ile Met Gly
Trp Leu Gly Met
Trp Leu Met Gly
Trp Met Ala Val
Trp Met Gly Ile
Trp Met Gly Leu
Trp Met Ile Gly
Trp Met Leu Gly
Trp Met Val Ala
Trp Pro Phe Gly
Trp Pro Gly Phe
Trp Val Ala Met
Trp Val Cys Val
Trp Val Met Ala
Trp Val Val Cys
3-(4-(N-Biotinoyl-6-aminocaproyloxy)phenyl)propionic acid
Methylstat
Methylstat is a potent histone demethylases inhibitor. Methylstat shows anti-proliferative activity with low cytotoxicity. Methylstat induces apoptosis and cell cycle arrest at G0/G1 phase. Methylstat increases the expression of p53 and p21 protein levels. Methylstat inhibits angiogenesis induced by various cytokines. Methylstat can be used as a chemical probe for addressing its role in angiogenesis[1][2].
methyl (3R,5S,7R,9R,10R)-10-[(2R,3E,5E,7Z)-7-(2,4-dioxopyrrolidin-3-ylidene)-7-hydroxy-4-methylhepta-3,5-dien-2-yl]-7-hydroxy-3,5,9-trimethyl-4,11,12-trioxatricyclo[6.3.1.01,5]dodecane-2-carboxylate
5-O-[(3R)-1-benzylpiperidin-3-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
4-[4-(4-fluorophenyl)-1-piperazinyl]-N-[4-methyl-2-(4-morpholinyl)-6-quinolinyl]-4-oxobutanamide
N-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
ethyl 7-benzyl-1-[2-(1H-indol-2-yl)ethyl]-5-phenyl-4,6-dihydrotriazolo[4,5-c]pyridine-7-carboxylate
2-[(4S,4aR,7R,8R,8aS)-7-hydroxy-8-(hydroxymethyl)-4a,8-dimethyl-2-pyridin-3-yl-4,5,6,7,8a,9-hexahydrobenzo[][1,3]benzothiazol-4-yl]-N-[(1R)-1-phenylethyl]acetamide
N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
5-O-[(3R)-1-benzylpiperidin-3-yl] 3-O-methyl (4S)-2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
N-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
3-fluoro-N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
4-methoxy-N-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[[(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
N-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-1-methyl-4-imidazolesulfonamide
N-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[[(2R,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[[(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[[(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
3-fluoro-N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
(S)-SNAP5114
(S)-SNAP5114 is a selective GABA transport inhibitor, with IC50 values of 5 μM and 21 μM for hGAT-3 and rGAT-2, respectively. (S)-SNAP5114 is an anticonvulsant agent[1][2].
BAN ORL 24
BAN ORL 24 is a nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP) antagonist. BAN ORL 24 has antagonistic effect for nociceptin (NOP) receptor with KI value of 0.24 nM in CHO cell. BAN ORL 24 can be used for the research of cancer and analgesic[1].